In pancreatic cancer cells, inhibition of the NFAT pathway using cyclosporin A (CsA) results in the suppression of c-myc transcription, leading to an increase in the G1 phase and a decrease in the S phase (Buchholz et al, 2006). This evidence concerns the gene MYC and pancreatic neoplasm.